Blume Capital Management, Inc. Nuvasive Inc Transaction History

Blume Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$42.51 - $54.02 $8,502 - $10,804	-200 Reduced 25.0%	600 $26,000
Q1 2022 May 12, 2022	SELL	$48.09 - $57.79 $9,618 - $11,558	-200 Reduced 20.0%	800 $45,000
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $56,910 - $67,810	1,000 New	1,000 $60,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Blume Capital Management, Inc. with notifications on news.